Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Due to the lender's worsening financial situation, the RBI imposed some limitations on Mumbai-based Raigad Sahakari Bank, including a withdrawal cap of Rs 15,000 per customer.
EXAMIANS